Navigation Links
Premier Research Expands Salt Lake City and Phoenix Testing Facilities Adding 50% Capacity
Date:2/16/2012

PHILADELPHIA, Feb. 16, 2012 /PRNewswire/ -- Premier Research Group Limited announces the opening of new state-of-the-art clinical research facilities located in Phoenix and Salt Lake City, increasing their testing facilities capacity by 50%.

"We are excited to be expanding our existing clinical research facilities to accommodate more phase 1 and outpatient studies," stated Michael Kuss, Vice President, Analgesia. "These new facilities give us the capability to reach and house more study volunteers as well as successfully conduct phase 2 and 3 chronic pain, migraine, dysmenorrhea, vaccine, obesity and other models at all our sites."

In addition to the full service CRO offerings, Premier Research owns and operates a network of clinical research centers designed to offer clinical site services from phase 1 proof of concept trials to phase 4 post-marketing trials primarily in the areas of healthy normal volunteers, acute and chronic pain, rheumatology, and neuroscience. Each of the centers has multiple experienced investigators and full-time Premier Research staff that are medically trained and highly experienced.

Premier Research has been in the Phoenix market since 1993 and in Salt Lake City since 1999. The Phoenix site is located in the Deer Valley Medical Center at 20414 N. 27th Avenue, Suite 200, and the Salt Lake City center is located at 3995 South 700 East #250.

About Premier Research
Premier Research is a professional services company providing clinical development support to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide. The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it has grown a strong strategic sourcing group that supports customers in their resource planning and management.

The company offers a comprehensive series of services for every phase of clinical development including regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.

For more information please visit, www.premier-research.com.


'/>"/>
SOURCE Premier Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City
2. Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations
3. Premier Research Achieves Double-Digit Growth in Functional Sourcing for the Third Straight Year
4. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
5. Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
6. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
7. Mexico Premiere for Money-Saving Pharma Leak Testing Equipment
8. Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners
9. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
10. Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29
11. Mathematics and Biochemistry Research Earn Top Prize at Nations Premier High School Science Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):